10 Best “Strong Buy” Stocks — JBLU GGAL CBPO and more

Advertisement

This week, these ten stocks, all currently earning A’s (“strong buy”) on Portfolio Grader, have the best year-to-date performance.

Since January 1, JetBlue Airways Corporation (JBLU) has jumped 40.3%. JetBlue Airways provides nonstop passenger flight service through its Airbus A320 aircraft. For more information, get Portfolio Grader’s complete analysis of JBLU stock.

The price of Grupo Financiero Galicia SA Sponsored ADR Class B (GGAL) is up 40.9% since the first of the year. Grupo Financiero Galicia is a financial services holding company. Trade volume has increased significantly over the past week, up 92.5%. The stock’s trailing PE Ratio is 7.30. For more information, get Portfolio Grader’s complete analysis of GGAL stock.

Since January 1, China Biologic Products, Inc. (CBPO) has shot up 46.3%. China Biologic Products is a biopharmaceutical company that engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers. Trade volume rose notably over the past week, up 260.5%. For more information, get Portfolio Grader’s complete analysis of CBPO stock.

Since January 1, the price of Impax Laboratories, Inc. (IPXL) has grown 48.2%. Impax Laboratories develops, manufactures, and markets both proprietary and multi-source pharmaceutical products utilizing its drug delivery technologies. For more information, get Portfolio Grader’s complete analysis of IPXL stock.

Since the first of the year, shares of Insperity, Inc. (NSP) have soared 56.9%. Insperity provides personnel management that encompasses a range of services, including benefits and payroll administration, health and workers’ compensation insurance programs and personnel records management. Trade volume has increased significantly over the past week, up 157%. For more information, get Portfolio Grader’s complete analysis of NSP stock.

Since January 1, Skechers U.S.A., Inc. Class A (SKX) has climbed 62.3%. Skechers USA designs, makes, markets and distributes footwear. For more information, get Portfolio Grader’s complete analysis of SKX stock.

Shares of Ellie Mae, Inc. (ELLI) have risen 63.2% since January 1. Ellie Mae provides business automation software for the mortgage industry in the United States. The volume of trades has grown significantly in the past week, up 483.9%. For more information, get Portfolio Grader’s complete analysis of ELLI stock.

Since January 1, Ebix, Inc. (EBIX) has jumped 67.7%. Ebix provides a series of application software products for the insurance industry, including carrier systems and agency systems. For more information, get Portfolio Grader’s complete analysis of EBIX stock.

Since the first of the year, the price of ABIOMED, Inc. (ABMD) has swelled 73.8%. Abiomed provides medical devices in circulatory support and it offers a continuum of care in heart recovery to acute heart failure patients. Trade volume rose notably over the past week, up 542.3%. For more information, get Portfolio Grader’s complete analysis of ABMD stock.

Shares of Chimera Investment Corporation (CIM) have leaped 344.1% since January 1. Chimera Investment is a specialty finance company that invests in residential mortgage-backed securities, residential mortgage loans, real estate-related securities, and various other asset classes. The stock currently has a trailing PE Ratio of 5.30. For more information, get Portfolio Grader’s complete analysis of CIM stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, https://investorplace.com/2015/05/10-best-strong-buy-stocks-jblu-ggal-cbpo-and-more-jblu-ggal-cbpo/.

©2024 InvestorPlace Media, LLC